Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Neurology & Psychiatry
Filter     Order     Display # 
Date Item Title
19 Dec 2007 Intra-cellular therapies presents preclinical data from schizophrenia and sleep maintenance programs
18 Dec 2007 EPIX Pharmaceuticals Reports Compelling Clinical Results for PRX-03140 in Alzheimer's Disease
18 Dec 2007 Lu AA21004 for the treatment of mood and anxiety disorders enters into clinical phase III
18 Dec 2007 Kalypsys Initiates Phase IIa Clinical Trial of Topical iNOS Inhibitor
18 Dec 2007 Prana Completes Final Patient Dosing in Phase IIa Trial of PBT2 in Alzheimer’s Disease Patients
18 Dec 2007 Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
18 Dec 2007 Allon Therapeutics completes dosing in Phase II clinical trial in Alzheimer’s program
17 Dec 2007 Pharming Starts Collaboration With Solvay And Academic Groups On Parkinson And Alzheimer Disease
17 Dec 2007 Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
17 Dec 2007 Successful transdermal oxycodone clinical trial results
17 Dec 2007 Lilly and BioMS Medical Announce Global Licensing and Development Agreement
17 Dec 2007 New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia
14 Dec 2007 Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
14 Dec 2007 Adolor Initiates Phase 2a Study of Delta Agonist ADL5859 in Neuropathic Pain
13 Dec 2007 Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
13 Dec 2007 Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
13 Dec 2007 Genmab announces details of planned Ofatumumab Phase II study in multiple sclerosis
13 Dec 2007 Oxford biomedica initiates Phase I/II trial of prosavin (R) gene-based treatment for parkinson's disease
13 Dec 2007 QRxPharma Initiates Second Phase III Clinical Trial for its “Dual Opioid” Pain Therapy
12 Dec 2007 Gene A/S begins Phase Ib clinical trial with NsG0202 for the treatment of Alzheimer's disease
12 Dec 2007 Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
12 Dec 2007 New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
12 Dec 2007 VIVUS Initiates Third Qnexa Phase 3 Trial in Obese Patients
12 Dec 2007 NeuroSearch's associated company NsGene A/S starts Phase Ib clinical study with NsG0202 for the treatment of Alzheimer's disease
12 Dec 2007 Theravance Announces Initiation of Phase 1 Clinical Study With Investigational Medicine For Respiratory Disease
12 Dec 2007 Vanda Presents Phase III Iloperidone Efficacy Data
11 Dec 2007 New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
10 Dec 2007 AVANIR Enrolls First Patient in Confirmatory Phase III Trial of Zenvia(TM) in PBA
10 Dec 2007 EntreMed Presents Results for Its Lead Aurora Kinase-Angiogenesis Inhibitor
10 Dec 2007 Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics’ Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
07 Dec 2007 Nycomed files marketing authorisation application for an intranasal fentanyl spray in Europe
07 Dec 2007 Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
06 Dec 2007 Ipsen submits a Biologics License Application (BLA) in cervical dystonia to the FDA for Dysport(R)
06 Dec 2007 Update on M6G
06 Dec 2007 Remoxy Meets Primary Endpoint in Pivotal Phase III Study
05 Dec 2007 Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
05 Dec 2007 Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
05 Dec 2007 ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
05 Dec 2007 Lexicon Initiates Phase 2A Trial of LX6171 Drug Candidate for Cognitive Disorders
04 Dec 2007 Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement
04 Dec 2007 Cannasat and IntelGenx Complete Phase 1 Study for CAT 310
04 Dec 2007 Cipher appeals FDA’s decision on cip-tramadol er
03 Dec 2007 Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson's Disease
03 Dec 2007 Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
03 Dec 2007 Targacept Announces Results of Phase II Study of TC-2696 in Postoperative Dental Pain
03 Dec 2007 UCB Announces Positive Phase III Trial Results for Keppra XR(TM)
03 Dec 2007 NeuroSearch initiates clinical Phase I study with NSD-644 as a potential new pain treatment
03 Dec 2007 Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
03 Dec 2007 UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
03 Dec 2007 Buck Institute and Neurobiological Technologies, Inc. Partner to Develop Treatment for Huntington's Disease
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 451 - 500 of 1619

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics